Getting your ADCs to the clinic: Considerations for early stage development 2013 is a seminar that provides guidance on the development of antibody-drug conjugates (ADCs), including:
Key parameters for non-clinical studies to support a Phase 1 clinical trial
CMC issues during the development of ADCs, with a particular focus on the assessment and control of the quality of such products
How to create an early phase product development plan that meets regulatory expectations
The factors that influence the choice of conjugate and linker types
Past Events
Getting your ADCs to the clinic: Considerations for early stage development 2013 - 02 Dec 2013, Holiday Inn London Bloomsbury, United Kingdom (39891)
Important
Please, check "Getting your ADCs to the clinic: Considerations for early stage development" official website for possible changes, before making any traveling arrangements
Event Categories
Health & Medicine: Medical laboratories, Medical technology, Pharma
